Last reviewed · How we verify
NCT07046442: PuReCOVID
Effect of Pulmonary Rehabilitation and Physical Activity on Long COVID (PuReCOVID)
trial testing Pulmonary Rehabilitation in Long COVID-19 Syndrome in 40 participants. Participants enrolled and being followed up; not accepting new ones.
4 February 2025
Quick facts
| Lead sponsor | University of Parma |
|---|---|
| Status | Active, enrolled |
| Study type | OBSERVATIONAL |
| Enrollment | 40 |
| Start date | 5 April 2022 |
| Primary completion | 4 February 2025 |
| Estimated completion | 30 December 2025 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Pulmonary Rehabilitation
Conditions studied
- Long COVID-19 Syndrome — all drugs for Long COVID-19 Syndrome →
Sponsor
University of Parma
Who can join
18 and older, any sex, with Long COVID-19 Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This single-center, observational, longitudinal, retrospective and prospective study investigates the impact of Active Cycle of Breathing Technique (ACBT) and moderate daily physical activity on symptoms associated with long COVID, such as cough, dyspnea, and fatigue. The study aims to assess whether these interventions can moderately alleviate or resolve these symptoms and evaluate their potential association with small airway dysfunction (SAD), as measured by Impulse Oscillometry (IOS). We will recruit 40 adult patients with long COVID who meet specific inclusion criteria. Participants will perform ACBT twice daily and complete at least 6000 steps per day for six weeks. We will track clinical and lung function parameters, including spirometry, IOS, and exercise capacity.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07046442
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Pulmonary Rehabilitation
Trials testing the same drug.
- NCT07197229 — Hospital- and Home-Based Structured Pulmonary Rehabilitation in Recently Admitted COPD Patients: A Quasi-Experimental St · NA · not yet recruiting
- NCT07376161 — Inflammation and Oxidative Stress in COPD · enrolling by invitation
- NCT07097961 — Paediatric Post-TB Pulmonary Rehab Study · NA · recruiting
- NCT06756230 — Downhill Walking in IPF · NA · recruiting
- NCT06707623 — CPET Guided Rehab vs Physiotherapy in Patients With Dysfunctional Breathing · NA · recruiting
Other recruiting trials for Long COVID-19 Syndrome
Currently open trials in the same condition.
- NCT07316127 — Immunoadsorption in Autoimmune Long COVID · Phase 2 · recruiting
- NCT07110714 — Effects of Kneipp Hydrotherapy in Post-COVID-19 Patients · NA · recruiting
- NCT06871293 — Evaluating the Impact of a Functional and Cognitive Strategy in Patients With Long Covid-19 · NA · recruiting
- NCT06940609 — Magnetic Resonance Analysis of Neural Inflammatory Factors and External Stimulation · Phase 2 · recruiting
Other University of Parma trials
Trials by the same sponsor.
- NCT07242079 — Effect Of Pulmonary Rehabilitation in Patients With Alpha-1 Antitrypsin Deficiency · completed
- NCT06977802 — Design and Implementation of a Mobile App for Promoting Healthy and Sustainable Eating Among Students at the University · NA · completed
- NCT06347094 — Precision Nutrition to Improve Cardiometabolic Health With Dietary (Poly)Phenols · NA · recruiting
- NCT06028659 — Investigation of in Vivo Endogenous and/or Exogenous Production of Phenolic Metabolites Using (un)Targeted Metabolomics · NA · recruiting
- NCT06455956 — Use of miRNAs in Growth Hormone Deficiency (GHD) · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07046442 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Parma
- Last refreshed: 1 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07046442.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing